NEW YORK (GenomeWeb) – Fitch Ratings today affirmed Quest Diagnostics' ratings at BBB with a stable ratings outlook. 

The rating action applies to about $3.86 billion of debt. 

Fitch noted Quest's leading position in a fragmented and competitive US clinical laboratory market, saying its scale "affords the opportunity for comparatively efficient operations and supplies sourcing, and the ability to drive associated margin improvement following" merger and acquisition deals. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.